There's been little improvement in treatment for dry eye disease over the past 20 years, but biotech analyst Difei Yang says new therapies are showing promise.

More than 20 REITs gathered at our conference in New York to discuss the trends and challenges in the real estate space. Here, we outline highlights from Equity Research Analyst Haendel St. Juste.

With NAFTA poised to be replaced by USMCA, the disruptions created when a continental trade agreement is renegotiated present challenges and opportunities for supply chain management, working capital, and capital expenditures.

With scientific breakthroughs in genomics, antibody discovery, and cell and gene therapies, oncology is expected to attract a bigger R&D spend globally than ever before.

From hopeless to hyper-targeted, Salim Syed walks us through the evolution of cancer treatments— from early surgery in ancient times to the exciting prospects for immunotherapy, targeting tell-tale neoantigen proteins that identify cancer cells.

We recap some of the top trends discussed at the inaugural summit, hosted by Mizuho Equity Research Analyst Gregg Moskowitz.

Contactless payments have faced a number of challenges in reaching widespread adoption, but as Mizuho’s Financial Technology and Payments Equity Research Analyst, Thomas McCrohan explains, transit is the first step in accelerating broader contactless adoption across the United States.

Autonomous driving faces a tough road ahead, but the latest technology aims to overcome safety and regulatory hurdles.

African Swine Fever has hit China's pork industry hard. With help from Proteins Analyst Jeremy Scott, we look at the global implications.